{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : true,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0006915",
      "entity_text" : "apoptosis",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:9875401",
      "entity_text" : "Rivaroxaban",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Preincubation of 786-O microvesicles, or alternatively the HCAEC with effective concentrations of Rivaroxaban (0.6 mug/mL) to inhibit any present fXa, did not prevent endothelial apoptosis (not shown).",
  "reading_complete" : "2020-08-03T14:24:43Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T14:22:51Z",
  "trigger" : "prevent",
  "evidence" : [ "Rivaroxaban (0.6 mug/mL) to inhibit any present fXa, did not prevent endothelial apoptosis" ],
  "pmc_id" : "6598090",
  "score" : 0
}